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When Is Diabetes Distress
Clinically Meaningful?
Establishing cut points for the Diabetes Distress Scale
LAWRENCE FISHER, PHD, ABPP1
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WILLIAM H. POLONSKY, PHD, CDE2
JOSEPH MULLAN, PHD3
OBJECTIVEdTo identify the pattern of relationships between the 17-item Diabetes Distress
Scale (DDS17) and diabetes variables to establish scale cut points for high distress among patients
with type 2 diabetes.
RESEARCH DESIGN ANDMETHODSdRecruited were 506 study 1 and 392 study 2
adults with type 2 diabetes from community medical groups. Multiple regression equations
associated the DDS17, a 17-item scale that yields a mean-item score, with HbA1c, diabetes
self-efficacy, diet, and physical activity. Associations also were undertaken for the two-item
DDS (DDS2) screener. Analyses included control variables, linear, and quadratic (curvilinear)
DDS terms.
RESULTSdSignificant quadratic effects occurred between the DDS17 and each diabetes vari-
able, with increases in distress associated with poorer outcomes: study 1 HbA1c (P, 0.02), self-
efficacy (P , 0.001), diet (P , 0.001), physical activity (P , 0.04); study 2 HbA1c (P , 0.03),
self-efficacy (P , 0.004), diet (P , 0.04), physical activity (P = NS). Substantive curvilinear
associations with all four variables in both studies began at unexpectedly low levels of DDS17: the
slope increased linearly between scores 1 and 2, was more muted between 2 and 3, and reached a
maximum between 3 and 4. This suggested three patient subgroups: little or no distress, ,2.0;
moderate distress, 2.0–2.9; high distress, $3.0. Parallel findings occurred for the DDS2.
CONCLUSIONSdIn two samples of type 2 diabetic patients we found a consistent pattern of
curvilinear relationships between the DDS and HbA1c, diabetes self-efficacy, diet, and physical
activity. The shape of these relationships suggests cut points for three patient groups: little or no,
moderate, and high distress.
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D iabetes distress (DD) refers to theunique, often hidden emotional bur-dens and worries that are part of the
spectrum of patient experience when man-
aging a severe, demanding chronic disease
like diabetes (1). High levels of DD are
common (prevalence, 18–35%; 18-month
incidence, 38–48%) and persistent over
time, and they are distinct from clinical de-
pression in their linkages with glycemic
control and disease management (2–4).
High levels of DD have been significantly
associated with poor glycemic control,
poor self-care, low diabetes self-efficacy,
and poor quality-of-life, even after control-
ling for clinical depression (5).
A critical concern is the establishment
of a reliable and valid cut point or crite-
rion to define high DD so that further
assessment and/or intervention might be
initiated. Use of a standard cut point also
enhances consistency of findings across
studies and provides a uniform criterion
for identifying patients at risk. In this
study, we examined the relationship be-
tween the 17-item Diabetes Distress Scale
(DDS17) (6), a widely used factor-
analyzed, theory-driven, self-report survey,
and several diabetes biologic and manage-
ment measures in two samples of patients
with type 2 diabetes. We also included a
comparable analysis of the 2-item DDS
(DDS2) screener, based on the 17-item
scale (7). Our goal was to identify the de-
gree and pattern of relationships between
DDS scores and diabetes behavioral and
biologic variables to define cut points for
high DD for use in clinical and research
settings.
Although there is no universally ap-
plicable method for determining a scale
cut point, empiric approaches fall into
two categories (8,9). A data-oriented ap-
proach dichotomizes a scale at a prespe-
cified point along the scale distribution
and compares those above the cut point
with those who reach criterion using a
gold standard measure. For example,
scores from the Patient Health Question-
naire 9 (10), a depression survey, were
compared with scores on a gold standard,
structured psychiatric interview like the
Comprehensive International Diagnostic
Interview (11). A second approach to
establishing a scale cut point is most often
used when no gold standard measure is
available or practical. It observes the cova-
rying relationships between the score dis-
tribution of the scale of interest with the
same respondents’ scores on other relevant
variables or outcomes. Using the DDS, for
example, we might observe the linear and
quadratic (curvilinear) relationships be-
tween DDS scores and scores on diabetes
self-efficacy, disease-management, and/or
HbA1c. This analysis would tell us not
only how substantive the relationships
were but also where along the scale distri-
butions these relationships occurred, what
form they took, and where a cut point
might best be placed.
Because we found no logical, face-
valid justification for selecting a specific
DDS score for a cut point and because
there currently is no gold standard mea-
sure of high DD, we adopted the latter
approach: the optimal categorization of
DD in relation to key diabetes-specific
biologic (HbA1c) and behavioral (e.g., di-
abetes self-efficacy, diet, physical activity)
variables, after adjusting for demographics
and disease status. Linear and nonlinear
termswere included to enhance comprehen-
siveness. Because the shape and degree of
relationship between score distributions can
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vary by patient sample, we separately an-
alyzed data from two independent com-





Baseline samples from two studies of de-
pression and distress among adult type 2
diabetic patients were included. Study 1,
our primary sample, used baseline data
from the Distress and Depression in Di-
abetes Study (3D Study), a noninterven-
tional, three-wave, 18-month study of the
prevalence and persistence of DD and de-
pressive symptoms among 506 adult type 2
diabetic patients (2). Data were collected
between 2003 and 2006. Study 2 used
baseline, preintervention data from the Re-
ducing Distress and Enhancing Effective
Management (REDEEM) Study, a random-
ized controlled trial designed to reduce DD
and enhancemanagement among 392 type
2 diabetic adults (12). These data were col-
lected between 2008 and 2010. Patients in
both studies were recruited using the dia-
betes registries of several Bay Area commu-
nity-based medical groups and diabetes
education centers.
Inclusion criteria for both studies were
patients with type 2 diabetes for 12months
or more, age 21 years or older, read and
speak English fluently, no severe diabetes
complications, and no active psychosis,
substance use, or dementia. Additional,
more restrictive criteria for REDEEM Study
patients included displaying a mean item
score of 1.5 or higher on the DDS2 to
indicate elevated DD, displaying a score
of 15 or higher on the Patient Health
Questionnaire 8 to exclude patients with
clinical depression, and displaying a def-
icit in at least one of three areas of dia-
betes self-management (diet, physical
activity, medication use). A modification
of the Summary of Diabetes Self-care Ac-
tivities (SDSCA) (13) was used to define a
deficit as not following their diet or phys-
ical activity plan 3 or more days during
the last week or not taking prescribed di-
abetes medications 2 or more days during
the last week.
Procedure
For both studies, letters were sent to each
patient from their health care facility,
cosigned by facility and project represen-
tatives, informing them of the project and
that they would receive a phone call from
the project office if one of two opt-out
procedures was not initiated: patient re-
turned an enclosed postcard or called an
800 phone number. A screening phone
call followed and, for eligible patients, an
appointment was made to explain the
project in detail, collect informed con-
sent, and begin the baseline assessment.
Baseline assessment in both studies in-
cluded a 1.5-h home visit for completion
of questionnaires, physical measurements,
and interviews, as well as a visit to a com-
munity laboratory for collection of blood
and urine specimens. All data included in
the present report were from the baseline
assessment only. Both studies were ap-
proved by the institutional review boards
at theUniversity ofCalifornia, SanFrancisco,
and at each participating facility.
Measures
Control variables for both studies included
patient age, sex (female = 1, male = 0),
education, ethnicity (white = 1, nonwhite =
0), years with type 2 diabetes, use of insulin
(yes or no), and BMI.
The DDS is a 17-item measure that
uses a Likert scale to score each item from
1 (no problem) to 6 (a serious problem)
during the lastmonth (a = 0.93) (6).Mean-
item scores are then calculated (DDS17).
Previous analyses identified that the
DDS2 had good sensitivity and specificity
with the DDS17 (7) and was considered a
reliable screening composite for use in
clinical practice.
The DDS17 and DDS2 were associated
with four diabetes-related variables. HbA1C
was collected at a community facility and
processed at the same community labora-
tory in both studies. Also included were
measures of diabetes self-efficacy, diet, and
physical activity, although different mea-
sures were used in each of the two studies.
3D Study. Diabetes Self-Efficacy is a 10-
item scale (a = 0.88), adapted fromCoyne
and Smith (14), that assesses the patient’s
perceived confidence about taking care of
diabetes (15). Items are rated on a 4-point
scale from “not at all sure” to “very sure.”
Diet and physical activity were assessed
by the Summary of Diabetes Self-care Ac-
tivities (13). Respondents indicated the
number of days during the past week
that they completed their diet and physi-
cal activity regimens.
REDEEM Study. Diabetes Self-Efficacy
was assessed by a 15-item scale developed
by Lorig et al. (16) (a = 0.88). Items are
rated on a 10-point Likert scale. Diet was
assessed by five items from the “Starting
the Conversation” survey (17) that asks
respondents to indicate the number of
times per week during the past 4 months
that they ate certain types of unhealthy
foods (e.g., fast foods, sodas, sweet tea).
Physical activity was assessed by the
Community Healthy Activities Model
Program for Seniors (18). Nineteen items
regarding frequency of specific physical
activities (e.g., walk fast or briskly, swim,
ride a bicycle) assessed caloric expendi-
tures per week in moderate-intensity
physical activity activities, capped at a
value of 6,000 calories (19).
Data analysis
Comparisons were undertaken between
3D and REDEEM on key patient demo-
graphics using x2 and t tests. Separate
step-wise multiple regression equations
were conducted for the DDS17 and
DDS2 for each of the four dependent var-
iables for each sample: step 1, demo-
graphics and disease status; step 2, DDS
score (linear term); step 3, DDS score
(quadratic term). Quadratic effects were
interpreted only if the related t test, with
one degree of freedom at step 3, was sig-
nificant. The goal in these analyses was to
determine if the shape of the relationships
yielded a common pattern that would
define a meaningful cut point for the
DDS17 and DDS2. A minimum change
of 0.5 SD units in dependent variables
was used to help establish cut points
(20). The results of each significant effect
were placed on scatterplots, with fitted
linear or quadratic lines, to examine the
shape and start-point of the relationship
between each DDS score and each of the
dependent variables. Mean-item DDS val-
ues up to 4.0 were plotted because these
encompassedmore than 90%of the sample
and DDS values .4 were based on small
numbers with greater error. Note that the
direction of the curves varies as a function
of the direction of the regression coefficient
and the direction of the scale.
RESULTS
3D Study
Details of the sample have been presented
previously (4). Screening identified 640
eligible patients and 506 participated
(79%), with no demographic or diabetes
status differences between those who did
and did not participate. The final sample
was 56.9% women, average age was
57.79 (SD, 9.84) years, and average years
since diagnosis was 8.14 (7.49) (Table 1).
About 37% self-identified as white, 87.7%
completed high school, and 15%of patients
were taking insulin.
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After step1 control variables were
entered into the equations, multiple re-
gression analyses indicated significant
linear and quadratic effects between the
DDS17 and each of the four dependent
variables (Table 2), with increases in DD
associated with poorer glycemic control
(P , 0.02), self-efficacy (P , 0.001),
diet (P , 0.001), and physical activity
(P = 0.04). Figure 1 indicates that sub-
stantive associations between DDS17
and diabetes variables were evident at
unexpectedly low levels of DDS17. Rela-
tionships between the DDS17 and the de-
pendent variables began linearly between
DDS17 scores of 1 and 2, continued but
were somewhat muted between DDS17
scores of 2 and 3, and reached a maxi-
mum between DDS17 scores of 3 and 4.
The significant increases in DDS17 mean-
item scores across the four diabetes varia-
bles increased by ;0.5 SD units for each
dependent variable for each of three
DDS17 score groups: below a DDS mean-
item score of 2 (n = 276, 54.6%of patients),
between a score of 2 and 3 (n = 139,
27.4%), and above 3 (n = 91, 18.0%).
Findings from the DDS2 analyses ap-
proximated those from the DDS17: after
control variableswere entered into the equa-
tions, significant linear and quadratic effects
were found for HbA1c (P = 0.02) and self-
efficacy (P, 0.001), but only significant lin-
ear effects were found for diet (P , 0.001)
and physical activity (P = 0.005; Table 1).
Furthermore, where they occurred, the
shape of the curvilinear relationships for
the DDS2 with the diabetes variables was
virtually identical to those found for the full
DDS17 scale (data not shown): substantive
linear relationships began between a mean
item score of 1 and 2, continued but were
muted between scores of 2 and 3, and
reached a maximum at a mean item score
of ;4. Likewise, about a half-SD unit of
change in each dependent variable oc-
curred up to a mean-item score of 2, be-
tween 2 and 3, and over 3.
REDEEM Study
Of 588 subjects who were screened as
eligible, 392 (67%) completed the base-
line assessment (Table 1). There were no
significant differences between participat-
ing and nonparticipating eligible patients
on demographics or disease status. Aver-
age age was 56.12 (SD, 9.5) years, 56.5%
were women, and diabetes duration was
7.9 (6.33) years. Almost all patients com-
pleted high school (97.4%), ;40% iden-
tified as white, and 18% were taking
insulin. Although REDEEM patients had
to meet more restrictive inclusion criteria
than 3D patients, between-group differ-
ences were minimal: REDEEM Study pa-
tients were slightly younger, had higher
education and initial diabetes distress, but
displayed no HbA1C differences (Table 1).
Results from the multiple regression
analyses for REDEEM paralleled 3D find-
ings. After the control variableswere entered
into the equations, significant quadratic
effects occurred for the DDS17 on HbA1c
(P = 0.03), self-efficacy (P , 0.004), and
diet (P = 0.04), but not on physical activity
(P = NS): high DDS17 was associated with
poor glycemic control, low self-efficacy, and
poor diet. As in the 3D Study, notable linear
associations between DDS17 and the diabe-
tes variables occurred between DDS17
scores of 1 and 2 (n = 135, 34.5% of pa-
tients), continued between DDS17 scores of
2 and 3 (n = 162, 41.3%), and a maximum
was observed between a mean-item score of
3 and 4 (n = 95, 24.2%), with approximate
changes in half-SD units of the dependent
variables for each of the 3 DDS score inter-
vals. Where they occurred, the degree and
shape of the quadratic effects were virtually
identical to those in the 3D Study (Fig. 1).
For the DDS2, significant curvilinear
effects occurred for HbA1c (P = 0.02), for
self-efficacy (P = 0.05), and for physical ac-
tivity (P = 0.03; Table 2).Where curvilinear
effects were found, substantive linear rela-
tionships occurred between a mean-item
score of 1 and 2, with more muted linear
increases between scores of 2 and 3, and a
maximumwas reached betweenmean-item
scores of 3 and 4. Approximate half-SD in-
creases in the dependent variables occurred
for each DDS2 score interval and the degree
and shape of the curves were identical to
those in the 3D Study (Fig. 1). Only signif-
icant linear effects occurred for the DDS2
on diet (b= 0.21, P , 0.001), with high
distress associated with poor diet.
CONCLUSIONSdSignificant curvilin-
ear relationships occur between the DDS17
and measures of glycemic control, diabetes-
specific self-efficacy, diet, and physical activ-
ity in two community-based samples of type
2 diabetic adults, with the exception of
physical activity in REDEEM. The degree
and shape of these relationships are almost
identical for two patient samples of type 2
diabetic adults: a highly diverse community
sample (3D Study) and a more restricted
community sample that displayedhigh initial
levels of distress, no clinical depression, and
poor self-management (REDEEM Study).
The similar degree and shape of rela-
tionships across studies, across dependent
variables, and across the DDS17 and DDS2
highlight two important findings with re-
spect to establishing a clinically meaningful
cut point for high distress. First, the signif-
icant relationship of diabetes-specific dis-
tress with each of the four dependent
Table 1dSample descriptions of 3D and REDEEM studies
Variable
3D Study REDEEM Study x2 or
Mean/n SD/% Mean/n SD/% t test P
Age (years) 57.80 9.85 56.10 9.56 2.60 0.01
Female sex 288 56.9% 211 53.8% 0.85 0.36
Education (years) 14.57 3.34 15.65 2.43 25.41 ,0.001
Years since diagnosis 8.14 7.50 7.93 6.33 0.45 0.66
White ethnicity 186 36.8% 157 40.1% 1.01 0.31
Insulin 76 15.0% 70 17.9% 1.28 0.26
BMI (kg/m2) 32.74 7.74 33.07 7.76 20.62 0.53
HbA1c 7.25 1.44 7.41 1.60 21.52 0.13
DDS17 2.10 0.96 2.40 0.88 24.72 ,0.001
DDS2 2.26 1.31 2.82 1.27 26.42 ,0.001
DDS4 2.25 1.26 2.79 1.19 26.45 ,0.001
Self-efficacy
Study 1 2.98 0.62 d d d d
Study 2 d d 6.51 1.6 d d
Diet
Study 1 4.13 1.56 d d d d
Study 2 d d 0.53 0.37 d d
Physical activity
Study 1 3.11 2.32 d d d d
Study 2 d d 1,899.52 1,797.27 d d
DDS4, four-item Diabetes Distress Scale.
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variables begins at unexpectedly low levels
of distressdfar less DD is required to
demonstrate a relationship with diabetes-
specific biologic and behavioral indicators
than was previously considered. A previ-
ous report suggested that a mean item
score of 3.0 provided a valid cut point
for highDD (7). Our new findings confirm
and expand these findings: even rela-
tively low levels of DD are associated
with diabetes-related indicators.
Second, to help determine where an
appropriate DDS cut point should be, we
focus on the notable consistency in the
shape of the significant curvilinear relation-
ships between the DDS17 across the de-
pendent variables in both 3DandREDEEM:
the curve rises linearly from a DDS17 mean
item score of 1 to 2, continues linearly but
in a more muted fashion between scores
of 2 and 3, and reaches a maximum be-
tween scores 3 and 4. We note also that,
in general, there is an ;0.5 SD increase in
each of the four dependent variables corre-
sponding to increases in DDS17mean item
scores from 1 to 2, 2 to 3, and above 3.
Findings for the DDS2 approximate
those for the DDS17, even with the many
fewer items and far less information con-
tained in DDS2. The similar pattern of
significant linear and curvilinear effects
across the four diabetes variables, the
similar degree of association, and the sim-
ilar shape of the respective curves of asso-
ciation all suggest that the DDS2 behaves
relatively similarly to the DDS17 with re-
spect to the four diabetes variables we
studied.
These findings suggest that dichoto-
mizing the distribution of DDS17 scores to
denote a “high distress” group and a “low
distress” group does not accurately reflect
the shape of the relationships between the
DDS17 and the four diabetes indicators. It
therefore may be more helpful to define
three DDS categories: “little or no DD”
(DDS ,2.0), “moderate DD” (DDS = 2.0–
2.9), and “high DD” (DDS$3.0). Creating
defined categories of moderate and high
DDprovides a better reflection of the shape
of these relationships across diabetes indi-
cators than a single cut point and allows
greater flexibility for use in clinical and re-
search settings.
3D Study results, based on a diverse
community sample, indicate that 45.4% of
patients with type 2 diabetes display at least
moderate DD. (Percentages for REDEEM
are considerably higherd65.5%dbecause
this study required high DD as an inclusion
criterion.) These findings suggest that sig-
nificant levels of DD occur among almost
half of patients with type 2 diabetes and
that the possible reciprocal influence of
DD on diabetes indicators indicates in-
creased risk for poor treatment outcomes.
Because ;70% of these patients are not
clinically depressed (2), interventions for
DD may best be focused on ongoing con-
versations about DD and diabetes manage-
ment in the clinical setting. Highly rated
DDS17 items can be used to identify areas
of specific patient concern, and patients are
often relieved when clinicians initiate a dis-
cussion that labels feelings overtly, links
them with diabetes-related difficulties,
and normalizes them in ways that provide
both reassurance and perspective (1). Even
Table 2dStandardized coefficients for DDS17 and DDS2 linear and curvilinear effects
Study
HbA1c Self-efficacy Healthy diet Physical activity
b P b P b P b P
3D
Step 1 Sex (female = 1) –0.02 0.58 –0.01 0.79 –0.01 0.99 –0.08 0.07
Age –0.12 0.01 0.14 0.01 0.18 ,0.001 0.07 0.12
Education –0.07 0.14 0.05 0.32 0.06 0.18 –0.01 0.97
Ethnicity (white = 1) –0.15 0.001 –0.16 0.001 –0.04 0.44 –0.01 0.90
Time since diagnosis 0.02 ,0.001 –0.13 0.02 –0.05 0.33 –0.04 0.42
Insulin 0.19 ,0.001 0.03 0.60 0.05 0.35 –0.03 0.59
BMI 0.06 0.20 –0.17 ,0.001 –0.15 0.001 –0.21 ,0.001
Step 2 DDS17 item linear 0.15 ,0.001 –0.44 ,0.001 –0.32 ,0.001 –0.10 0.03
Step 3 DDS17 item linear 0.25 ,0.001 –0.71 ,0.001 –0.48 ,0.001 –0.19 0.003
DDS17 item quadratic –0.14 0.02 0.39 ,0.001 0.22 ,0.001 0.13 0.04
Step 2 DDS2 item screener linear 0.17 ,0.001 –0.50 ,0.001 –0.32 ,0.001 –0.13 0.01
Step 3 DDS2 item screener linear 0.26 ,0.001 –0.61 ,0.001 –0.35 ,0.001 –0.17 0.006
DDS2 screener quadratic –0.14 0.02 0.22 ,0.001 0.05 0.37 0.07 0.28
REDEEM
Step 1 Sex (female = 1) –0.02 0.61 –0.07 0.18 0.01 0.97 –0.29 ,0.001
Age –0.20 ,0.001 0.12 0.02 –0.06 0.32 –0.12 0.02
Education 0.02 0.76 0.03 0.61 –0.05 0.38 0.01 0.94
Ethnicity (white = 1) –0.11 0.04 0.03 0.53 –0.04 0.42 0.01 0.81
Time since diagnosis 0.16 0.01 0.06 0.29 –0.02 0.76 –0.01 0.89
Insulin 0.23 ,0.001 –0.05 0.66 0.03 0.65 –0.02 0.65
BMI –0.01 0.83 –0.11 0.03 0.13 0.01 0.01 0.82
Step 2 DDS17 item linear 0.04 0.42 –0.38 ,0.001 0.22 ,0.001 –0.07 0.15
Step 3 DDS17 item linear 0.11 0.07 –0.47 ,0.001 0.22 ,0.001 –0.12 0.05
DDS17 item quadratic –0.13 0.03 0.16 0.01 –0.13 0.04 0.08 0.17
Step 2 DDS2 item screener linear 0.10 0.06 –0.37 ,0.001 0.21 ,0.001 –0.05 0.37
Step 3 DDS2 item screener linear 0.15 0.007 –0.42 ,0.001 0.22 ,0.001 –0.10 0.08
DDS2 screener quadratic –0.13 0.02 0.10 0.05 –0.02 0.69 0.12 0.03
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the verbalization of emotional experiences
surrounding diabetes can be therapeutic
and can lead to action planning for behav-
ioral change.
Several limitations are worthy of note.
First, we included only four diabetes var-
iables for study. The DDS17 may display
different levels and patterns of association
with other diabetes-related indicators. Sec-
ond, we did not explore how patient de-
mographic and diabetes-related factors
qualify these relationships; instead, we
controlled for many of them in equations.
Although our goal was to report findings
with the greatest generalizability, differ-
ences in results may occur for subgroups
of patients. Last, our findings are cross-
sectional and associational, such that
causation between DD and diabetes indi-
cators cannot be inferred. A previous study
suggested that these associations are bidi-
rectional (2), with one affecting the other
sequentially over time.
We used a data-oriented approach to
establish empirically DDS cut points for
significant diabetes distress among adult
patients with type 2 diabetes. In two com-
munity samples we show a consistent pat-
tern of curvilinear relationships between the
DDS and HbA1c, diabetes self-efficacy, diet,
and physical activity. The degree and shape
of these relationships suggest cut points on
the DDS17 and the DDS2 for three patient
subgroups: those with little or no distress,
moderate distress, and high distress.
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